Back to Journals » Clinical Pharmacology: Advances and Applications
Clinical Pharmacology: Advances and Applications
ISSN: 1179-1438

Editor-in-Chief: Professor Arthur E Frankel
Clinical Pharmacology: Advances and Applications is an international, peer-reviewed, open access, online journal, that focuses on the publication of clinical trials with a special interest in early clinical trials and the pharmacologic behavior of drugs and agents. The journal is dedicated to publishing rapidly all scientifically sound clinical trials whatever the outcome and it is therefore essential that they also report the detailed pharmacologic information/data. The journal aims at publishing articles that will allow predictions to be made from drug chemistry and pharmacology for eventual benefits and side effects. The journal provides the best available evidence to support decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by patients. The journal considers original research, methodology papers, short reports, reviews and commentaries in all areas of drug experience in humans.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (251)
- Volume 14, 2022 (8)
- Volume 13, 2021 (27)
- Volume 12, 2020 (28)
- Volume 11, 2019 (16)
- Volume 10, 2018 (19)
- Volume 9, 2017 (19)
- Volume 8, 2016 (20)
- Volume 7, 2015 (14)
- Volume 6, 2014 (23)
- Volume 5, 2013 (30)
- Volume 4, 2012 (11)
- Volume 3, 2011 (7)
- Volume 2, 2010 (28)
- Volume 1, 2009 (1)
Latest articles:
- 5 records -
Neural Net Modeling of Checkpoint Inhibitor Related Myocarditis and Steroid Response
Stefanovic F, Gomez-Caminero A, Jacobs DM, Subramanian P, Puzanov I, Chilbert MR, Feuerstein SG, Yatsynovich Y, Switzer B, Schentag JJ
Clinical Pharmacology: Advances and Applications 2022, 14:69-90
Published Date: 10 August 2022
Clinical Impact of Semaglutide, a Glucagon-Like Peptide-1 Receptor Agonist, on Obesity Management: A Review
Alorfi NM, Algarni AS
Clinical Pharmacology: Advances and Applications 2022, 14:61-67
Published Date: 3 August 2022
Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
Kosmas CE, Bousvarou MD, Sourlas A, Papakonstantinou EJ, Peña Genao E, Echavarria Uceta R, Guzman E
Clinical Pharmacology: Advances and Applications 2022, 14:49-59
Published Date: 16 July 2022

Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019


Ahmedalgabri RHM, Omer T, Zarroug F, Elkhawad AO, Noma M
Clinical Pharmacology: Advances and Applications 2022, 14:37-47
Published Date: 5 April 2022
Evaluating Pharmacists’ Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi Arabia
Alorfi N, Ashour A
Clinical Pharmacology: Advances and Applications 2022, 14:27-35
Published Date: 5 April 2022